Comments
Loading...

Inhibitor Therapeutics

INTIOTCQB
Logo brought to you by Benzinga Data
$0.0740
-0.00100-1.33%
At close: -

Inhibitor Therapeutics (OTC:INTI) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Inhibitor Therapeutics (INTI)?

A

There have been no specific sales or earnings guidance reported for Inhibitor Therapeutics in recent months.

Browse guidance and forecast on all stocks.